Dren Bio
Foster City, US · Founded 2019 · Delaware corporation · 10 known investors
Find your way into Dren Bio
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
Founders & leadership
Dren Bio was founded in 2019 by Nenad Tomasevic.
NT
Nenad TomasevicChief Executive Officer, Founder
Board
IT
Ivan TrifunovichBoard director
JW
John WesleyBoard director
Investors · 10
8VCAustin · $100K – $50Mvia Alex Kolicich · board
Aisling CapitalNew York
Mission Bay CapitalSan Francisco
Mission BiocapitalSan Francisco · $500K
Olive Tree CapitalBoston
SR One Capital ManagementRedwood Cityvia Rajeev Dadoo · board
Taiho Ventures, LLCMenlo Parkvia Sakae Asanuma · board
AlexandriareportedPasadena
Biotechnology Value FundreportedSan Francisco
HBM Healthcare Investmentsreported · 2 sourcesZug
Reported raises · per SEC filings
Form D private placements$93.1M disclosed across 3 rounds · 2019–2022
▶$62.5MraisedMar 2022 · 27 investors · BiotechnologyRule 506(b)
▶$62.5MraisedMar 2022 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rajeev DadooDirector
- Nenad TomasevicExecutive Officer, Director
- Andrew N. SchiffDirector
- Alex KolicichDirector
- Chandra LeoDirector
- Kenneth R LuehrsenDirector
- Sakae AsanumaDirector
- Offering amount
- $80M
- Amount sold
- $62.5M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$25.5MraisedNov 2020 · 11 investors · BiotechnologyRule 506(b)
▶$25.5MraisedNov 2020 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alex KolicichDirector
- Rajeev DadooDirector
- Sakae AsanumaDirector
- John WesleyDirector
- Nenad TomasevicExecutive Officer, Director
- Offering amount
- $60M
- Amount sold
- $25.5M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$5.1MraisedJul 2019 · 19 investors · OtherRule 506(b)
▶$5.1MraisedJul 2019 · 19 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Nenad TomasevicExecutive Officer, Director
- Ivan TrifunovichDirector
- John WesleyDirector
- Offering amount
- $6M
- Amount sold
- $5.1M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
RenBio22 shared keywordsRenBio develops DNA-based therapeutic technology that uses intramuscular injection of therapeutic-encoding "bioblueprints" so a patient's own muscle cells produce antibodies and therapeutic proteins to prevent and treat diseases, including infectious diseases. The company works in the antibody and therapeutic protein field, aiming to overcome obstacles in delivery, durability, and cost.
Mission BioCapital Platinum Program Holdings LLC16 shared keywordsMission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.
Companies competing with Dren Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Dren Bio do?
- Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
- Who founded Dren Bio?
- Dren Bio was founded by Nenad Tomasevic in 2019.
- Who are Dren Bio's investors?
- Dren Bio's investors include 8VC, Aisling Capital, Mission Bay Capital, Mission Biocapital, Olive Tree Capital, SR One Capital Management, Taiho Ventures, LLC, Alexandria and 2 more.
- How much funding has Dren Bio raised?
- Dren Bio has disclosed $93.1M raised across 3 rounds.
- Where is Dren Bio headquartered?
- Dren Bio is headquartered in Foster City, US.